T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fidelity National Information Services
FIS
|
+$3.15B |
| 2 |
Global Payments
GPN
|
+$2B |
| 3 |
NextEra Energy
NEE
|
+$1.82B |
| 4 |
Salesforce
CRM
|
+$1.51B |
| 5 |
Boeing
BA
|
+$1.38B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
WP
Worldpay, Inc.
WP
|
+$3.23B |
| 2 |
DATA
Tableau Software, Inc.
DATA
|
+$1.76B |
| 3 |
TSS
Total System Services, Inc.
TSS
|
+$1.49B |
| 4 |
Bank of America
BAC
|
+$1.43B |
| 5 |
Elevance Health
ELV
|
+$1.39B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.27% |
| 2 | Healthcare | 16.18% |
| 3 | Financials | 13.98% |
| 4 | Consumer Discretionary | 13.5% |
| 5 | Industrials | 10.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1201
ADT
ADT
$5.44B
| $16.8M | ﹤0.01% |
2,674,138
+2,181,284
| +443% | +$12.4M |
|
1202
Steel Dynamics
STLD
$37.3B
| $16.6M | ﹤0.01% |
558,043
-5,934
| -1% | -$175K |
|
1203
Rocket Pharmaceuticals
RCKT
$361M
| $16.5M | ﹤0.01% |
1,416,945
+243,999
| +21% | +$3.03M |
|
1204
PTC
PTC
$16.4B
| $16.5M | ﹤0.01% |
241,880
-63,048
| -21% | -$4.61M |
|
1205
Integer Holdings
ITGR
$4.26B
| $16.4M | ﹤0.01% |
216,713
+1,954
| +0.9% | +$155K |
|
1206
PVH
PVH
$3.77B
| $16.4M | ﹤0.01% |
185,384
-812
| -0.4% | -$67.8K |
|
|
CDK
1207
DELISTED
CDK Global, Inc.
CDK
| $16.3M | ﹤0.01% |
338,556
-62,008
| -15% | -$2.97M |
|
1208
CytomX Therapeutics
CTMX
$721M
| $16.3M | ﹤0.01% |
2,205,101
-595,771
| -21% | -$5.88M |
|
1209
Aramark
ARMK
$16.4B
| $16.2M | ﹤0.01% |
515,370
-7,541,500
| -94% | -$212M |
|
1210
Zymeworks
ZYME
$1.77B
| $16.2M | ﹤0.01% |
652,016
+348,595
| +115% | +$8.73M |
|
|
LL
1211
DELISTED
LL Flooring Holdings, Inc.
LL
| $16.2M | ﹤0.01% |
1,637,468
-1,138,812
| -41% | -$11.2M |
|
|
DCPH
1212
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $16.1M | ﹤0.01% |
+475,504
| New | +$14.1M |
|
|
HZN
1213
DELISTED
Horizon Global Corporation
HZN
| $16.1M | ﹤0.01% |
4,222,490
+734,562
| +21% | +$3.01M |
|
|
TECX
1214
Tectonic Therapeutic
TECX
$670M
| $16.1M | ﹤0.01% |
95,039
+27,686
| +41% | +$6.27M |
|
1215
Kimco Realty
KIM
$16.4B
| $16M | ﹤0.01% |
767,219
-2,108,943
| -73% | -$40.1M |
|
|
AVLR
1216
DELISTED
Avalara, Inc.
AVLR
| $16M | ﹤0.01% |
237,178
-171
| -0.1% | -$13.8K |
|
1217
Sabre
SABR
$892M
| $15.8M | ﹤0.01% |
705,481
+13,293
| +2% | +$313K |
|
1218
Pacira BioSciences
PCRX
$928M
| $15.6M | ﹤0.01% |
409,320
+4,947
| +1% | +$197K |
|
1219
Zai Lab
ZLAB
$2.92B
| $15.5M | ﹤0.01% |
477,921
+46,588
| +11% | +$1.6M |
|
1220
Red Rock Resorts
RRR
$3.76B
| $15.4M | ﹤0.01% |
759,948
+793
| +0.1% | +$16.6K |
|
|
SFIX
1221
Stitch Fix
SFIX
$474M
| $15.4M | ﹤0.01% |
800,443
-137,799
| -15% | -$3.2M |
|
|
AYX
1222
DELISTED
Alteryx Inc
AYX
| $15.4M | ﹤0.01% |
143,146
-56,510
| -28% | -$7.01M |
|
|
AIV
1223
Aimco
AIV
$382M
| $15.3M | ﹤0.01% |
2,204,403
-97,408
| -4% | -$660K |
|
1224
Axalta
AXTA
$7.98B
| $15.2M | ﹤0.01% |
505,443
-4,098
| -0.8% | -$121K |
|
1225
F5
FFIV
$23.3B
| $15.2M | ﹤0.01% |
108,189
-4,207
| -4% | -$582K |
|
Similar funds
T. Rowe Price Associates's Q3 2019 Portfolio in Review
As of Q3 2019, T. Rowe Price Associates held 2,592 positions worth $706B, down 0.8% from $712B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Trading was light in Q3 2019: portfolio turnover was 4.9%. T. Rowe Price Associates opened 52 new positions and exited 74, leaving the 2,592-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q3 2019 buy was The Southern Company: 9,440,159 shares worth $502M.
- T. Rowe Price Associates added most to Fidelity National Information Services in Q3 2019, an estimated $3.15B increase.
- T. Rowe Price Associates's biggest Q3 2019 reduction was Bank of America, cutting an estimated $1.43B.
- T. Rowe Price Associates fully exited Worldpay, Inc. in Q3 2019, selling an estimated $3.23B.
- T. Rowe Price Associates's ten largest holdings make up 21% of its $706B portfolio in Q3 2019.
- T. Rowe Price Associates opened 52 new positions and closed 74 in Q3 2019.
- T. Rowe Price Associates's portfolio value fell 0.8% quarter-over-quarter to $706B.
Based on T. Rowe Price Associates's 13F filing for Q3 2019, filed 14 Nov 2019.